These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 30281314)

  • 1. Acetalated Dextran Microparticles for Codelivery of STING and TLR7/8 Agonists.
    Collier MA; Junkins RD; Gallovic MD; Johnson BM; Johnson MM; Macintyre AN; Sempowski GD; Bachelder EM; Ting JP; Ainslie KM
    Mol Pharm; 2018 Nov; 15(11):4933-4946. PubMed ID: 30281314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A robust microparticle platform for a STING-targeted adjuvant that enhances both humoral and cellular immunity during vaccination.
    Junkins RD; Gallovic MD; Johnson BM; Collier MA; Watkins-Schulz R; Cheng N; David CN; McGee CE; Sempowski GD; Shterev I; McKinnon K; Bachelder EM; Ainslie KM; Ting JP
    J Control Release; 2018 Jan; 270():1-13. PubMed ID: 29170142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-COBRA hemagglutinin formulated with cGAMP microparticles elicits protective immune responses against influenza viruses.
    Zhang X; Shi H; Hendy DA; Bachelder EM; Ainslie KM; Ross TM
    mSphere; 2024 Jul; 9(7):e0016024. PubMed ID: 38920382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of tunable acetalated dextran microparticle platform to optimize M2e-based influenza vaccine efficacy.
    Chen N; Gallovic MD; Tiet P; Ting JP; Ainslie KM; Bachelder EM
    J Control Release; 2018 Nov; 289():114-124. PubMed ID: 30261204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tunable degradation of acetalated dextran microparticles enables controlled vaccine adjuvant and antigen delivery to modulate adaptive immune responses.
    Chen N; Johnson MM; Collier MA; Gallovic MD; Bachelder EM; Ainslie KM
    J Control Release; 2018 Mar; 273():147-159. PubMed ID: 29407676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of acetalated-dextran microparticle fabrication methods for a clinically translatable subunit-based influenza vaccine.
    Pena ES; Batty CJ; Hendy DA; Yang S; Ontiveros-Padilla L; Stiepel RT; Ting JP; Ainslie KM; Bachelder EM
    Int J Pharm; 2024 Mar; 652():123836. PubMed ID: 38266940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A microparticle platform for STING-targeted immunotherapy enhances natural killer cell- and CD8
    Watkins-Schulz R; Tiet P; Gallovic MD; Junkins RD; Batty C; Bachelder EM; Ainslie KM; Ting JPY
    Biomaterials; 2019 Jun; 205():94-105. PubMed ID: 30909112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vivo and Cellular Trafficking of Acetalated Dextran Microparticles for Delivery of a Host-Directed Therapy for Salmonella enterica Serovar Typhi Infection.
    Johnson MM; Collier MA; Hoang KV; Pino EN; Graham-Gurysh EG; Gallovic MD; Zahid MSH; Chen N; Schlesinger L; Gunn JS; Bachelder EM; Ainslie KM
    Mol Pharm; 2018 Nov; 15(11):5336-5348. PubMed ID: 30296381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-COBRA hemagglutinin formulated with cGAMP microparticles elicit protective immune responses against influenza viruses.
    Zhang X; Shi H; Hendy DA; Bachelder EM; Ainslie KM; Ross TM
    bioRxiv; 2024 Feb; ():. PubMed ID: 38464191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Powerful Complex Immunoadjuvant Based on Synergistic Effect of Combined TLR4 and NOD2 Activation Significantly Enhances Magnitude of Humoral and Cellular Adaptive Immune Responses.
    Tukhvatulin AI; Dzharullaeva AS; Tukhvatulina NM; Shcheblyakov DV; Shmarov MM; Dolzhikova IV; Stanhope-Baker P; Naroditsky BS; Gudkov AV; Logunov DY; Gintsburg AL
    PLoS One; 2016; 11(5):e0155650. PubMed ID: 27187797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a biodegradable microparticulate polymer as a carrier for Burkholderia pseudomallei subunit vaccines in a mouse model of melioidosis.
    Schully KL; Bell MG; Prouty AM; Gallovic MD; Gautam S; Peine KJ; Sharma S; Bachelder EM; Pesce JT; Elberson MA; Ainslie KM; Keane-Myers A
    Int J Pharm; 2015 Nov; 495(2):849-61. PubMed ID: 26428631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TLR4 and TLR7/8 Adjuvant Combinations Generate Different Vaccine Antigen-Specific Immune Outcomes in Minipigs when Administered via the ID or IN Routes.
    McKay PF; King DF; Mann JF; Barinaga G; Carter D; Shattock RJ
    PLoS One; 2016; 11(2):e0148984. PubMed ID: 26862758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injectable, Ribbon-Like Microconfetti Biopolymer Platform for Vaccine Applications.
    Moore KM; Batty CJ; Stiepel RT; Genito CJ; Bachelder EM; Ainslie KM
    ACS Appl Mater Interfaces; 2020 Sep; 12(35):38950-38961. PubMed ID: 32805875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The STING ligand cGAMP potentiates the efficacy of vaccine-induced CD8+ T cells.
    Gutjahr A; Papagno L; Nicoli F; Kanuma T; Kuse N; Cabral-Piccin MP; Rochereau N; Gostick E; Lioux T; Perouzel E; Price DA; Takiguchi M; Verrier B; Yamamoto T; Paul S; Appay V
    JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30944257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplexed electrospray enables high throughput production of cGAMP microparticles to serve as an adjuvant for a broadly acting influenza vaccine.
    Batty CJ; Gallovic MD; Williams J; Ross TM; Bachelder EM; Ainslie KM
    Int J Pharm; 2022 Jun; 622():121839. PubMed ID: 35623484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release.
    Ilyinskii PO; Roy CJ; O'Neil CP; Browning EA; Pittet LA; Altreuter DH; Alexis F; Tonti E; Shi J; Basto PA; Iannacone M; Radovic-Moreno AF; Langer RS; Farokhzad OC; von Andrian UH; Johnston LP; Kishimoto TK
    Vaccine; 2014 May; 32(24):2882-95. PubMed ID: 24593999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of STING agonists for adjuvanting subunit vaccines.
    Van Herck S; Feng B; Tang L
    Adv Drug Deliv Rev; 2021 Dec; 179():114020. PubMed ID: 34756942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degradation of acetalated dextran can be broadly tuned based on cyclic acetal coverage and molecular weight.
    Chen N; Collier MA; Gallovic MD; Collins GC; Sanchez CC; Fernandes EQ; Bachelder EM; Ainslie KM
    Int J Pharm; 2016 Oct; 512(1):147-157. PubMed ID: 27543351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.
    Goff PH; Hayashi T; He W; Yao S; Cottam HB; Tan GS; Crain B; Krammer F; Messer K; Pu M; Carson DA; Palese P; Corr M
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STING Agonist Mitigates Experimental Autoimmune Encephalomyelitis by Stimulating Type I IFN-Dependent and -Independent Immune-Regulatory Pathways.
    Johnson BM; Uchimura T; Gallovic MD; Thamilarasan M; Chou WC; Gibson SA; Deng M; Tam JW; Batty CJ; Williams J; Matsushima GK; Bachelder EM; Ainslie KM; Markovic-Plese S; Ting JP
    J Immunol; 2021 May; 206(9):2015-2028. PubMed ID: 33820855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.